BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24740084)

  • 1. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
    Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
    J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
    Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
    Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
    Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
    Zheng F; Zha H; Yang D; Deng J; Zhang Z
    Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.
    Sarwar M; Gardezi SAH; Zaman G; Ikram A; Satti L; Khadim MT
    J Pak Med Assoc; 2020 Mar; 70(3):442-446. PubMed ID: 32207422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients].
    Zeng SY; Liu T; Meng WT; Chen YN
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):43-6. PubMed ID: 21429401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of serum galactomannan and β-D-glucan for invasive aspergillosis in suspected patients: A meta-analysis.
    Huang QY; Li PC; Yue JR
    Medicine (Baltimore); 2024 Feb; 103(5):e37067. PubMed ID: 38306560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.
    Furfaro E; Mikulska M; Del Bono V; Guolo F; Minetto P; Gobbi M; Ghiso A; Bacigalupo A; Viscoli C
    Clin Vaccine Immunol; 2014 Sep; 21(9):1357-9. PubMed ID: 24990906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
    Metan G; Ağkuş C; Buldu H; Koç AN
    Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.
    Aubry A; Porcher R; Bottero J; Touratier S; Leblanc T; Brethon B; Rousselot P; Raffoux E; Menotti J; Derouin F; Ribaud P; Sulahian A
    J Clin Microbiol; 2006 Feb; 44(2):389-94. PubMed ID: 16455889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis.
    Scotter JM; Campbell P; Anderson TP; Murdoch DR; Chambers ST; Patton WN
    Pathology; 2005 Jun; 37(3):246-53. PubMed ID: 16175901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.
    Hachem RY; Kontoyiannis DP; Chemaly RF; Jiang Y; Reitzel R; Raad I
    J Clin Microbiol; 2009 Jan; 47(1):129-33. PubMed ID: 19005145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of the serum galactomannan and (1, 3)-β-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Cai X; Ni W; Wei C; Cui J
    Intern Med; 2014; 53(21):2433-7. PubMed ID: 25366000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.